Jérôme Thiry

Variations of circulating cardiac biomarkers during and after anthracycline-containing chemotherapy in breast cancer patients

Pierre Frères, Nassim Bouznad, Laurence Servais et al. · BMC Cancer · 2018 · 82 citations · Full text

Medicine, Cardiology, Oncology +17

<scp><i>GREB1L</i></scp> variants in familial and sporadic hereditary urogenital adysplasia and <scp>Mayer‐Rokitansky‐Kuster‐Hauser</scp> syndrome

Adeline Jacquinet, Bouchra Boujemla, Corinne Fasquelle et al. · Clinical Genetics · 2020 · 71 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

Circulating microRNA-based screening tool for breast cancer

Pierre Frères, Stéphane Wenric, Meriem Boukerroucha et al. · Oncotarget · 2015 · 63 citations · Full text

Medicine, Molecular Biology, Oncology +17

Blood eosinophilic relative count is prognostic for breast cancer and associated with the presence of tumor at diagnosis and at time of relapse

Concetta Elisa Onesti, Claire Josse, Delphine Boulet et al. · OncoImmunology · 2020 · 31 citations · Full text

Medicine, Hematology, Oncology +13

Differences in plasma microRNA content impair microRNA-based signature for breast cancer diagnosis in cohorts recruited from heterogeneous environmental sites

Jeanne P. Uyisenga, Ahmed Debit, Christophe Poulet et al. · Scientific Reports · 2021 · 12 citations · Full text

Medicine, Biomedical Sciences, Oncology +17